AKTX - Akari Therapeutics Plc
1.393
0.023 1.651%
Share volume: 22,567
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.37
0.02
0.02%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-19-2024 | 05-15-2024 | 08-19-2024 | 11-19-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 4.594 M | 4.615 M | 2.507 M | 5.989 M | 5.555 M | 1.852 M | |
| Selling general and admin | 2.863 M | 3.091 M | 2.821 M | 3.710 M | 2.241 M | 1.709 M | |
| Research and development | 1.731 M | 1.524 M | -314.000 K | 2.279 M | 3.314 M | 143.000 K | |
| Total expenses | 4.594 M | 4.615 M | 2.507 M | 5.989 M | 7.449 M | 2.927 M | |
| 0.46% | -45.68% | 138.89% | 24.38% | -60.71% | |||
| Operating income | -4.594 M | -4.615 M | -2.507 M | -5.989 M | -7.449 M | -2.927 M | |
| Ebit | 971.000 K | -4.029 M | -2.865 M | -5.566 M | -7.509 M | -2.829 M | |
| Pretax income | 1.001 M | -4.000 M | -2.849 M | -5.566 M | -7.558 M | -2.895 M | |
| -499.60% | -28.78% | 95.37% | 35.79% | -61.70% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 1.001 M | -4.000 M | -2.871 M | -5.566 M | -7.558 M | -2.895 M | |
| -499.60% | 28.23% | -93.87% | -35.79% | 61.70% |
